Exploring how ubiquitin helps cells respond to oxidative stress
Defining Novel Roles of Ubiquitin Accumulation During the Mammalian Oxidative Stress Response
This study looks at how a tiny protein called ubiquitin helps our cells deal with stress from things like UV rays and pollution, which could lead to better ways to understand and fight diseases like cancer and heart problems.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11090537 on NIH RePORTER |
What this research studies
This research investigates the role of ubiquitin accumulation in the cellular response to oxidative stress caused by environmental factors like UV radiation and air pollutants. By examining how ubiquitin modifications affect cellular processes such as protein degradation and antioxidant production, the study aims to uncover new mechanisms that help cells survive under stress. The research utilizes advanced techniques to analyze the effects of these modifications in mammalian cells, particularly focusing on how they influence cellular defense mechanisms. Patients may benefit from a better understanding of how oxidative stress contributes to diseases like cancer and atherosclerosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals exposed to environmental stressors that may lead to oxidative stress-related diseases.
Not a fit: Patients with conditions unrelated to oxidative stress or those not exposed to relevant environmental factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating diseases linked to oxidative stress.
How similar studies have performed: Previous research has shown promising results in understanding the role of ubiquitin in cellular stress responses, indicating potential for success in this area.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Maduka, Austin O. — Duke University
- Study coordinator: Maduka, Austin O.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.